Company news
Corline Biomedical AB news in 2025
Corline Biomedical AB's news releases, calls and decks from 2025, newest first.
CLBIO: Breakthrough quarter with FDA approval, long-term deal, and capital raise set stage for growth
November 18, 2025
Corline Biomedical Signs 10-Year Agreement With Kardium
September 30, 2025
CLBIO: Growth depends on Kardium's US launch, with cost cuts improving results despite lower sales
August 26, 2025
CLBIO: Corline's Q1 2025 loss widens, but US market entry and strong clinical data drive optimism
May 8, 2025
CLBIO: 2024 saw heavy losses and restructuring, but Corline targets US growth with CHSTM-coated Globe®
February 17, 2025